Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot-to-lot consistency study of group A and C meningococcal polysaccharide conjugate vaccine in healthy children
ChiCTR2000038950Phase 4Recruiting
- Sponsor
- Shaanxi Provincial Center for Disease Control and Prevention
- Start
- Jul 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in meningococcal disease (4 arms), sponsored by Shaanxi Provincial Center for Disease Control and Prevention. Primary endpoint: Serum bactericidal antibody titer by rSBA before and after immunization. Started Jul 2020; status: recruiting.
02
Drugs
Group A and C Meningococcal Polysaccharide Conjugate Vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on ChiCTR2000038950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038950.